The Development of a New Triphasic Oral Contraceptive 1980
DOI: 10.1007/978-94-011-6666-9_2
|View full text |Cite
|
Sign up to set email alerts
|

The rationale for a new triphasic contraceptive

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1982
1982
2010
2010

Publication Types

Select...
3
2
1

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Introduction of the triphasic principle allowed a dose reduction of older generation progestageus without sacrificing cycle control [6]. Dose reduction was aimed at lowering possible side-effects caused by the synthetic steroids administered.…”
Section: Discussionmentioning
confidence: 99%
“…Introduction of the triphasic principle allowed a dose reduction of older generation progestageus without sacrificing cycle control [6]. Dose reduction was aimed at lowering possible side-effects caused by the synthetic steroids administered.…”
Section: Discussionmentioning
confidence: 99%
“…The first modification to dosing was, thus, a decrease in the oestrogen dose. This occurred fairly quickly: COCs with 30 mg ethinylestradiol (EE) were released in the early 1970s 6 . Attempts were also made to reduce the overall dose of steroids being consumed by developing phasic pills 6,7 .…”
Section: The Development Of New Dosing Regimensmentioning
confidence: 99%
“…This occurred fairly quickly: COCs with 30 mg ethinylestradiol (EE) were released in the early 1970s 6 . Attempts were also made to reduce the overall dose of steroids being consumed by developing phasic pills 6,7 . At the same time, efforts were made to reduce progestogen-influenced side effects and androgenic effects on lipid and glucose metabolism 8 .…”
Section: The Development Of New Dosing Regimensmentioning
confidence: 99%
“…These effects were mainly arterial, and it therefore became the aim to reduce progestogen content of oral contraceptives as well as the oestrogen. While maintaining cycle control, this was possible by introducing the biphasic and triphasic preparations, where the progestogen dose increases from 50 µg per day to 125 µg per day 30 . The triphasic preparation resulted in a 39% reduction in the dose of levonorgestrel ingested each month.…”
Section: Reducing the Dose Of Progestogen In The Oral Contraceptivementioning
confidence: 99%